Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra
Q2 2026 drug catalysts put Replimune, Arvinas and Boehringer in sharp focus: GlobalData
Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment
ZEISS India strengthens portfolio with the launch of ZEISS ClearMind lenses
Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy
Biogen to buy Apellis Pharmaceuticals for $5.6B in rare disease and immunology push
Orca Bio’s Orca-T FDA review extended to July 2026
Emcure Pharma reduces Poviztra starting dose price by 55% in India
Agilent opens new customer experience center in Mumbai
Lupin completes acquisition of VISUfarma
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes